Terray Therapeutics seals $60m Series A

Terray Therapeutics, a biotechnology company, has closed $60 million in Series A financing.

Terray Therapeutics, a biotechnology company, has closed $60 million in Series A financing. Madrona Venture Group led the round with participation from other investors that include Two Sigma Ventures, Digitalis Ventures, KdT Ventures, Goldcrest Capital, XTX Ventures, Sahsen Ventures, Greentrail Capital and Alexandria Venture Investments.

Source: Press Release